Why Traditional Biomanufacturing Models are Faltering
July 29, 2026
As product pipelines become more varied, biomanufacturers are rethinking how facilities, data systems and workforce skills support day-to-day operations
6 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
FOYA: Celebrating Innovation in Pharma Facilities
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
Latest News
All the latest Medicine Maker articles.
Single-Cell Analysis Reveals Hidden CAR T Manufacturing Risks
July 23, 2026
Mission Bio’s Mike Molnar explains how single-cell multiomics could improve vector copy number analysis, product characterization, and safety assessment in CAR T development
5 min read
Why Drug Development Still Lacks Integration
July 21, 2026
John McDermott reflects on why early drug development remains fragmented – and how integrated approaches may shorten timelines
4 min read
The Power List 2026 is Live
July 21, 2026
We celebrate 60 inspiring individuals helping turn pharma’s boldest ideas into reality
2 min read
This Week’s CGT News: First-in-Human Diabetes Cell Therapy
July 20, 2026
First-in-human diabetes cell replacement, early iPSC-derived CAR T data in systemic sclerosis, AAV gene therapy for fragile X syndrome, and fresh funding for off-the-shelf CAR T
4 min read
Roving Reporter Asks: How Close Are We to Making CGT Production More Scalable and Repeatable?
July 20, 2026
IBTV speaks with industry leaders at Meeting on the Med 2026 to explore how automation, digitization, and new manufacturing models could make cell and gene therapy production more reproducible, efficient, and accessible
1 min read
Biopharma Vital Signs – Part 5: Capabilities for a Changing Landscape
July 17, 2026
Experts discuss the capabilities companies need to make drug development faster, more flexible, and more resilient – from integrated development and manufacturing flexibility to digital tools, supply chain strategy, and sharper decision-making
13 min read
The Rise of China: From Science Cities to Global Ambition
July 15, 2026
Daphne Smyth of Veristat on the rise of Chinese biopharma, regulatory realities, and what comes next
8 min read
Surviving CGT's Funding Winter
July 15, 2026
In the first installment of a new series on the investment environment in cell and gene therapy, Circio CEO Erik Wiklund explains how he had to get creative to raise funds in a difficult biotech market
10 min read
Smart Manufacturing Reaches the Bioprocessing Bench
July 14, 2026
Researchers retrofit a lab-scale monoclonal antibody purification platform with automation, OPC-UA connectivity, and model-based flow control
3 min read
Inside VIVEbiotech’s Work with Zelluna on TCR-NK Cell Therapy
July 14, 2026
VIVEbiotech CEO Jon Alberdi lifts the lid on an eight-year collaboration focused on GMP lentiviral vectors for off-the-shelf solid tumor therapies
3 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.